Articles written by: Nicole Straley

This is the "wpengine" admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.

Comparison of ERYTECH Pharma S.A. (ERYP) and INmune Bio Inc. (NASDAQ:INMB)

We are comparing ERYTECH Pharma S.A. (NASDAQ:ERYP) and INmune Bio Inc. (NASDAQ:INMB) on their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ERYTECH Pharma S.A. N/A […]

Reviewing Alector Inc. (ALEC)’s and Sesen Bio Inc. (NASDAQ:SESN)’s results

Both Alector Inc. (NASDAQ:ALEC) and Sesen Bio Inc. (NASDAQ:SESN) are Biotechnology companies, competing one another. We will compare their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alector Inc. 28.36M 44.27 62.37M -0.76 0.00 […]

KKR & Co. Inc. (KKR)’s Financial Results Comparing With AllianzGI Equity & Convertible Income Fund (NYSE:NIE)

KKR & Co. Inc. (NYSE:KKR) and AllianzGI Equity & Convertible Income Fund (NYSE:NIE) compete with each other in the Asset Management sector. We will analyze and compare their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing Umpqua Holdings Corporation (UMPQ)’s and Preferred Bank (NASDAQ:PFBC)’s results

As Regional – Pacific Banks businesses, Umpqua Holdings Corporation (NASDAQ:UMPQ) and Preferred Bank (NASDAQ:PFBC), are affected by compare. This especially applies to their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Umpqua Holdings Corporation […]

Trevi Therapeutics Inc. (TRVI) and NovaBay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) Comparison side by side

Trevi Therapeutics Inc. (NASDAQ:TRVI) and NovaBay Pharmaceuticals Inc. (NYSEAMERICAN:NBY) compete with each other in the Biotechnology sector. We will analyze and contrast their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trevi Therapeutics Inc. […]

Tonix Pharmaceuticals Holding Corp. (TNXP)’s Financial Results Comparing With DBV Technologies S.A. (NASDAQ:DBVT)

Both Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and DBV Technologies S.A. (NASDAQ:DBVT) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing CohBar Inc. (CWBR)’s and Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA)’s results

This is a contrast between CohBar Inc. (NASDAQ:CWBR) and Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA) based on their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Zynerba Pharmaceuticals Inc. (ZYNE) and Homology Medicines Inc. (NASDAQ:FIXX) Comparing side by side

Since Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) and Homology Medicines Inc. (NASDAQ:FIXX) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation of both companies. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]